[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Sopharma AD (SFA) - Financial and Strategic SWOT Analysis Review

October 2021 | 37 pages | ID: S46D67C8EA7EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Sopharma AD (SFA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sopharma AD (Sopharma) focuses on the manufacturing of pharmaceutical products and distribution of health related products. The company is also involved in non
  • pharma activities which includes manufacturing of consumables, dressing materials, apparatus, manufacturing of plastic disposable materials for the hospital market; and manufacturing of infusion solutions, injection solutions and veterinary medical products. Sopharma is specialized in manufacturing of non-sterile liquids/solutions, sterile dosage forms and manufacturing of semisolid and solid dosage form. The company also offers technological transfer of customer-developed products, EU batch release and batch control, Cleaning validation, Process validation, EU primary and secondary packaging services for international markets, EU-GMP compliant pharmaceutical contract manufacturing. Sopharma is headquartered in Sofia, Bulgaria.

    Key benefits of buying this profile include:

    You get detailed information about the company and its operations to identify potential customers and suppliers.
    • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
    Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
    • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
    • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
    • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
    Gain key insights into the company for academic or business research.
    • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Sopharma AD - Key Facts
    Sopharma AD - Key Employees
    Sopharma AD - Key Employee Biographies
    Sopharma AD - Major Products and Services
    Sopharma AD - History
    Sopharma AD - Company Statement
    Sopharma AD - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Joint Venture

    SECTION 2 – COMPANY ANALYSIS

    Company Overview
    Sopharma AD - Business Description
    Business Segment: Distribution of Pharmaceutical Products
    Performance
    Business Segment: Other
    Performance
    Business Segment: Production of Pharmaceutical Products
    Performance
    Geographical Segment: Bulgaria
    Performance
    Geographical Segment: Europe
    Performance
    Geographical Segment: Other Countries
    Performance
    Sopharma AD - SWOT Analysis
    SWOT Analysis - Overview
    Sopharma AD - Strengths
    Sopharma AD - Weaknesses
    Sopharma AD - Opportunities
    Sopharma AD - Threats
    Sopharma AD - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
    Sopharma AD, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
    Sopharma AD, Recent Deals Summary

    SECTION 5 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Sopharma AD, Key Facts
    Sopharma AD, Key Employees
    Sopharma AD, Key Employee Biographies
    Sopharma AD, Major Products and Services
    Sopharma AD, History
    Sopharma AD, Subsidiaries
    Sopharma AD, Joint Venture
    Sopharma AD, Key Competitors
    Sopharma AD, Ratios based on current share price
    Sopharma AD, Annual Ratios
    Sopharma AD, Annual Ratios (Cont...1)
    Sopharma AD, Annual Ratios (Cont...2)
    Sopharma AD, Interim Ratios
    Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
    Sopharma AD, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
    Sopharma AD, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Sopharma AD, Performance Chart (2016 - 2020)
    Sopharma AD, Ratio Charts
    Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
    Sopharma AD, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


    More Publications